Increased urinary albumin excretion rate in breast cancer patients

Acta Oncologica

Volumn 39, Issue 2, 2000, Pages 145-149

  Pedersen, Lars Møller ^a,b   Sørensen, Peter G ^a  

^a ROSKILDE HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; EARLY DIAGNOSIS; EXCRETION; FEMALE; HUMAN; METASTASIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; SURVIVAL RATE; URINALYSIS;

EID: 0034123051     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600430699     Document Type: Article

References (24)

1. Norris SH. Paraneoplastic glomerulopathies. Semin Nephrol 1993; 13: 258-72.
2. Sawyer N, Wadsworth J, Wijnen M, Gabriel R. Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies, Br Med J 1988; 296: 1295-8.
3. Roumen RMH, Wijnen MHA. Proteinuria: a frequent paraneoplastic phenomenon in colorectal cancer. Eur J Cancer 1998; 34: 206-7.
4. Georgiannos SN, Weston PM, Goode AW. Correlation between albuminuria and positively charged amino acids in gastrointestinal cancer. Int Surg 1995; 80: 49-52.
5. Kaplan BS, Klassen J, Gault MH. Glomerular injury in patients with neoplasia. Annu Rev Med 1976; 27: 117-25.
6. Fer MF, McKinney TD, Richardson RL, Hande KR, Oldham RK, Greco FA. Cancer and the kidney: renal complications of neoplasms. Am J Med 1981; 71: 704-18.
7. Pedersen LM, Milman N. Prevalence and prognostic significance of proteinuria in patients with lung cancer. Acta Oncol 1996; 35: 691-5.
8. Pedersen LM, Milman N, Microalbuminuria in patients with lung cancer. Eur J Cancer 1998; 34: 76-80.
9. Yamauchi H, Linsey MS, Biava CG, Hopper J. Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med 1985; 145: 2061-3.
10. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer: a syllabus derived from findings of the National Surgical Adjuvant Breast Project. Cancer 1975; 36: 1-85.
11. Marshall SM. Screening for microalbuminuria: which measurement? Diabetic Med 1991; 8: 706-11.
12. Meyrier A, Delahousse M, Callard P, Rainfray M. Minimal change nephrotic syndrome revealing solid tumours. Nephron 1992; 61: 220-3.
13. Ghosh L, Muehrcke RC. The nephrotic syndrome: a prodrome to lymphoma, Ann Intern Med 1979; 72; 379-82.
14. Barton CH, Vaziri ND, Spear GS. Nephrotic syndrome associated with adenocarcinoma of the breast. Am J Med 1980; 68: 308-12.
15. Rowe DJF, Sawnay A, Watts GF. Microalbuminuria in diabetes mellitus: Review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 1990; 27: 297-312.
16. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. The Copenhagen City Heart Study Group. Urinary albumin excretion in a population based sample of 1 011 middle aged non-diabetic subjects. Scand J Clin Lab Invest 1993; 53: 867-72.
17. Watts GF, Morris RW, Khan K, Polak A. Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation, Clin Chim Acta 1988; 172: 191-8.
18. Cirillo M, Senigalliesi L, Laurenzi M, et al. Microalbuminuria in nondiabetic adults. Arch Intern Med 1998; 158: 1933-9.
19. Feldt-Rasmussen B, Mathiesen ER, Variability of urinary albumin excretion in incipient diabetic nephropathy. Diab Nephrol 1984; 3: 101-3.
20. Hortobagyi GN, Smith TL, Legha SS, et al. Multivariate analysis of prognostic factors of metastatic breast cancer. J Clin Oncol 1983: 1: 776-86.
21. Fey MF, Brunner KW, Sonntag RW. Prognostic factors in metastatic breast cancer. Cancer Clin Trials 1981; 4: 237-47.
22. Blanco G, Hollf K, Heikkin M, et al. Prognostic factors in recurrent breast cancer: relationship to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 1990; 62: 142-6.
23. Carter CL, Allen C, Henson DE, et al. Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-7.
24. Osborne CK. Prognostic factors for breast cancer; have they met their promise? J Clin Oncol 1992; 10: 679-82.